Sweden · Delayed Price · Currency is SEK AcuCort AB Statistics
Total Valuation
AcuCort AB has a market cap or net worth of SEK 135.51 million. The enterprise value is 103.06 million.
| Market Cap | 135.51M |
| Enterprise Value | 103.06M |
Important Dates
The next estimated earnings date is Friday, November 28, 2025.
| Earnings Date | Nov 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AcuCort AB has 234.44 million shares outstanding. The number of shares has increased by 180.61% in one year.
| Current Share Class | 234.44M |
| Shares Outstanding | 234.44M |
| Shares Change (YoY) | +180.61% |
| Shares Change (QoQ) | +16.05% |
| Owned by Insiders (%) | 0.32% |
| Owned by Institutions (%) | 18.17% |
| Float | 233.69M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 16.95 |
| PB Ratio | 1.94 |
| P/TBV Ratio | 2.05 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.28 |
| EV / Sales | 12.89 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.79
| Current Ratio | 7.79 |
| Quick Ratio | 7.60 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -219.32 |
Financial Efficiency
Return on equity (ROE) is -39.80% and return on invested capital (ROIC) is -25.15%.
| Return on Equity (ROE) | -39.80% |
| Return on Assets (ROA) | -23.73% |
| Return on Invested Capital (ROIC) | -25.15% |
| Return on Capital Employed (ROCE) | -34.80% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 4 |
| Asset Turnover | 0.12 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -42.77% in the last 52 weeks. The beta is 1.19, so AcuCort AB's price volatility has been higher than the market average.
| Beta (5Y) | 1.19 |
| 52-Week Price Change | -42.77% |
| 50-Day Moving Average | 0.61 |
| 200-Day Moving Average | 0.73 |
| Relative Strength Index (RSI) | 50.01 |
| Average Volume (20 Days) | 263,401 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, AcuCort AB had revenue of SEK 8.00 million and -24.08 million in losses. Loss per share was -0.15.
| Revenue | 8.00M |
| Gross Profit | -10.99M |
| Operating Income | -24.34M |
| Pretax Income | -24.08M |
| Net Income | -24.08M |
| EBITDA | n/a |
| EBIT | -24.34M |
| Loss Per Share | -0.15 |
Balance Sheet
The company has 32.44 million in cash and n/a in debt, giving a net cash position of 32.44 million or 0.14 per share.
| Cash & Cash Equivalents | 32.44M |
| Total Debt | n/a |
| Net Cash | 32.44M |
| Net Cash Per Share | 0.14 |
| Equity (Book Value) | 69.96M |
| Book Value Per Share | 0.30 |
| Working Capital | 30.02M |
Cash Flow
| Operating Cash Flow | -15.16M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | -137.40% |
| Operating Margin | -304.49% |
| Pretax Margin | -301.13% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AcuCort AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -180.61% |
| Shareholder Yield | n/a |
| Earnings Yield | -17.77% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AcuCort AB has an Altman Z-Score of 15.31 and a Piotroski F-Score of 2.
| Altman Z-Score | 15.31 |
| Piotroski F-Score | 2 |